Better Therapeutics announced today that it expects its merger with Mountain Crest Acquisition Corp to close next month.
San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. At the time of the announcement, the companies expected the merger to be completed some time in the summer of 2021.
Get the full story at our sister site, Drug Delivery Business News.